ICP36 DNA Binding Protein (CMV ICP36) antibody

Details for Product No. ABIN265543
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Reactivity
Cytomegalovirus (CMV)
(1)
Host
Mouse
(1)
Clonality (Clone)
Monoclonal ()
Application
Western Blotting (WB), Immunofluorescence (IF), ELISA
(1), (1), (1)
Pubmed 9 references available
Quantity 100 μg
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN265543
247.50 $
Plus shipping costs $45.00 and if applicable $26.40 dry ice

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Clone 10D8
Isotype IgG1 kappa
Purification Affinity Purified
Purity > 95 % IgG by SDS-PAGE
Background Synonyms: pUL44, MDBP, pp52, DB52
Research Area Virology
Application Notes Western Blotting: > 1:80.000. Immunofluorescence: 1+ at 1:12.800. ELISA: 0.100 at 1:102.400
Restrictions For Research Use only
Concentration 1.0 mg/ml
Buffer Phosphate Buffered Saline pH 7.4 (no azide)
Preservative Azide free
Supplier Images
anti-ICP36 DNA Binding Protein (CMV ICP36) antibody Immunofluorescence
anti-ICP36 DNA Binding Protein (CMV ICP36) antibody (2) Western Blotting
anti-ICP36 DNA Binding Protein (CMV ICP36) antibody (3) Cross reactivity results
Product cited in: Perng, Qian, Fehr et al.: "The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts." in: Journal of virology, Vol. 85, Issue 10, pp. 4841-52, 2011 (PubMed).

Hwang, Saffert, Kalejta: "Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication." in: mBio, Vol. 2, Issue 2, pp. e00023-11, 2011 (PubMed).

Hakki, Drummond, Houser et al.: "Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection." in: Antiviral research, Vol. 92, Issue 2, pp. 313-8, 2011 (PubMed).

Strang, Boulant, Kirchhausen et al.: "Host cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments." in: mBio, Vol. 3, Issue 1, 2012 (PubMed). (1:100).

Gudleski-ORegan, Greco, Cristea et al.: "Increased Expression of LDL Receptor-Related Protein 1 during Human Cytomegalovirus Infection Reduces Virion Cholesterol and Infectivity." in: Cell host & microbe, Vol. 12, Issue 1, pp. 86-96, 2012 (PubMed).

Albright, Kalejta: "Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations." in: Journal of virology, 2013 (PubMed).

Qin, Penkert, Kalejta: "Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency." in: Journal of virology, 2013 (PubMed).

Ponroy, Taveira, Mueller et al.: "Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains." in: Journal of medical virology, 2014 (PubMed).

General Kim, Kim, Huh et al.: "Role of non-covalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth." in: Journal of virology, 2010 (PubMed).

Validation Images
Did you look for something else?
back to top